BioSpace News Archive

FDA

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease

Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo® (crizanlizumab-tmca), previously known as SEG101, to reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in adult and pediatric patients aged 16 years and older with sickle cell disease

November 15, 2019
·
12 min read
BioCapital

FDA In Brief: FDA recommends discarding or destroying yellowfin/ahi tuna imported from Truong Phu Xanh Co., LTD with production dates in 2019

“Based on our traceback investigation of recent cases of Scombrotoxin fish poisoning, the FDA is warning all sectors of the supply chain to discard certain tuna supplied by Truong Phu Xanh Co., LTD of Vietnam and advising consumers not eat any of this product.

November 15, 2019
·
3 min read
Global Medical Sensors Market 2019-2023 | Evolving Opportunities With First Sensor AG and HONEYWELL INTERNATIONAL INC. | Technavio

Technavio has announced its latest market research report titled global medical sensors market 2019-2023.

November 15, 2019
·
4 min read
Global Sinus Dilation Devices Market 2019-2023| Evolving Opportunities with Intersect ENT, Inc. and Medtronic | Technavio

Technavio has announced its latest market research report titled global sinus dilation devices market 2019-2023

November 15, 2019
·
4 min read